San Diego Pacific Oncology & Hematology Associates
4 clinical trials · Sponsor
◉ Watch San Diego Pacific Oncology & Hematology Associates
| Record | Firm | Date |
|---|---|---|
| Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma (NCT00489944) | San Diego Pacific Oncology & Hematology Associates | 2007-05-01 |
| Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma (NCT00538005) | San Diego Pacific Oncology & Hematology Associates | 2007-05-01 |
| Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma (NCT00492505) | San Diego Pacific Oncology & Hematology Associates | 2007-04-01 |
| Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas (NCT00492687) | San Diego Pacific Oncology & Hematology Associates | 2006-12-01 |
Track San Diego Pacific Oncology & Hematology Associates automatically
Every clearance here is in the API, with alerts when new ones post.